OTCMKTS:ZYXI - Zynex Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $5.28 -0.03 (-0.56 %) (As of 04/22/2019 04:00 PM ET)Previous Close$5.31Today's Range$5.16 - $5.3052-Week Range$2.40 - $5.90Volume71,494 shsAverage Volume41,917 shsMarket Capitalization$170.22 millionP/E Ratio24.00Dividend YieldN/ABeta1.05 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Receive ZYXI News and Ratings via Email Sign-up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ZYXI Previous Symbol CUSIPN/A CIK846475 Webwww.zynexmed.com Phone303-703-4906Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio3.23Price-To-Earnings Trailing P/E Ratio24.00 Forward P/E Ratio18.86 P/E GrowthN/A Sales & Book Value Annual Sales$23.43 million Price / Sales7.26 Cash Flow$0.2948 per share Price / Cash Flow17.91 Book Value$0.15 per share Price / Book35.20Profitability EPS (Most Recent Fiscal Year)$0.22 Net Income$7.36 million Net Margins33.33% Return on Equity152.81% Return on Assets95.46%Miscellaneous EmployeesN/A Outstanding Shares32,238,000Market Cap$170.22 million Next Earnings DateN/A OptionableNot Optionable Zynex (OTCMKTS:ZYXI) Frequently Asked Questions What is Zynex's stock symbol? Zynex trades on the OTCMKTS under the ticker symbol "ZYXI." How were Zynex's earnings last quarter? Zynex Inc. (OTCMKTS:ZYXI) released its earnings results on Tuesday, February, 26th. The company reported $0.08 earnings per share for the quarter, meeting the consensus estimate of $0.08. The firm had revenue of $9.34 million for the quarter, compared to analyst estimates of $8.82 million. Zynex had a return on equity of 152.81% and a net margin of 33.33%. View Zynex's Earnings History. What guidance has Zynex issued on next quarter's earnings? Zynex issued an update on its first quarter 2019 earnings guidance on Tuesday, February, 26th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $8.3-8.8 million, compared to the consensus revenue estimate of $8.07 million. What price target have analysts set for ZYXI? 1 analysts have issued 12-month target prices for Zynex's stock. Their forecasts range from $7.00 to $7.00. On average, they anticipate Zynex's stock price to reach $7.00 in the next year. This suggests a possible upside of 32.6% from the stock's current price. View Analyst Price Targets for Zynex. What is the consensus analysts' recommendation for Zynex? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zynex. Has Zynex been receiving favorable news coverage? News articles about ZYXI stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Zynex earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the near future. Who are some of Zynex's key competitors? Some companies that are related to Zynex include Viewray (VRAY), BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI), Cutera (CUTR), Electrocore (ECOR), Edap Tms (EDAP), BioSig Technologies (BSGM), Fonar (FONR), Second Sight Medical Products (EYES), Stereotaxis (STXS), IRIDEX (IRIX), Helius Medical Technologies (HSDT), Soleno Therapeutics (SLNO) and Viveve Medical (VIVE). What other stocks do shareholders of Zynex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Zynex investors own include Micron Technology (MU), Ctrip.Com International (CTRP), FuelCell Energy (FCEL), Alphabet (GOOG), Melinta Therapeutics (MLNT), Netflix (NFLX), Anadarko Petroleum (APC), Colgate-Palmolive (CL), Dollar General (DG) and Duke Energy (DUK). Who are Zynex's key executives? Zynex's management team includes the folowing people: Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 60)Mr. Daniel J. Moorhead, Chief Financial Officer (Age 47)Mr. David B. Mogill, VP of OperationsMr. Robert Bird, VP of MarketingMr. Steve Siefring, Director of Bus. Devel. How do I buy shares of Zynex? Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Zynex's stock price today? One share of ZYXI stock can currently be purchased for approximately $5.28. How big of a company is Zynex? Zynex has a market capitalization of $170.22 million and generates $23.43 million in revenue each year. The company earns $7.36 million in net income (profit) each year or $0.22 on an earnings per share basis. What is Zynex's official website? The official website for Zynex is http://www.zynexmed.com. How can I contact Zynex? Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company can be reached via phone at 303-703-4906 or via email at [email protected] MarketBeat Community Rating for Zynex (OTCMKTS ZYXI)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 110 (Vote Outperform)Underperform Votes: 101 (Vote Underperform)Total Votes: 211MarketBeat's community ratings are surveys of what our community members think about Zynex and other stocks. Vote "Outperform" if you believe ZYXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZYXI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/22/2019 by MarketBeat.com StaffFeatured Article: What is the Rule of 72?